Zolpidem - Prices & Where to Buy

What Is Zolpidem?

Zolpidem is a medication belonging to the imidazopyridine class, used as a sedative-hypnotic for the short-term treatment of insomnia. It is most commonly known by its brand name, Ambien, and is available in several formulations.

Zolpidem was first approved by the FDA in 1992 and has become one of the most widely prescribed sleep medications in the United States. It is available in immediate-release (Ambien), extended-release (Ambien CR), sublingual (Edluar, Zolpimist), and oral spray (ZolpiMist) formulations.

Zolpidem is designated as a Schedule IV controlled substance under the federal Controlled Substances Act due to its potential for abuse, dependence, and withdrawal.

How Zolpidem Works

Zolpidem works by binding to the GABA-A receptor, specifically at the benzodiazepine binding site. GABA-A is the primary inhibitory neurotransmitter receptor in the brain, and its activation produces sedation, anxiolysis, and muscle relaxation.

Unlike benzodiazepines, zolpidem has relative selectivity for the alpha-1 subunit of the GABA-A receptor, which is primarily associated with sedation. This selectivity is thought to produce more targeted sedative effects with less anxiolytic and muscle-relaxant activity compared to benzodiazepines.

Zolpidem has a rapid onset of action (15-30 minutes) and a relatively short half-life of approximately 2.5 hours for the immediate-release formulation. The extended-release formulation (Ambien CR) has a biphasic release profile: an initial rapid release for sleep onset and a slower release for sleep maintenance.

FDA Schedule & Classification

FDA-Approved Uses

Zolpidem is FDA-approved for the short-term treatment of insomnia characterized by difficulty falling asleep. It is intended for use when sleep initiation is clearly problematic.

• Insomnia characterized by difficulty falling asleep: Zolpidem helps reduce the time it takes to fall asleep (sleep latency) and increase total sleep time.
• Short-term use only: Recommended duration is generally 2 to 4 weeks. Long-term use has not been adequately studied.
• Not for sleep maintenance: Immediate-release zolpidem is primarily effective for sleep onset, not for middle-of-the-night awakenings.

The FDA has issued specific dosing recommendations based on gender due to pharmacokinetic differences between men and women (see Dosing section below).

Dosage Forms & Strengths

Immediate-Release (IR) Tablets

Extended-Release (ER) Tablets (Ambien CR)

Sublingual Tablets (Edluar) and Oral Spray (Zolpimist)

Side Effects

Common Side Effects

These are the most frequently reported side effects of zolpidem:

• Drowsiness (next-day somnolence) — especially at higher doses; risk of impaired driving
• Dizziness
• Headache
• Diarrhea
• Dry mouth
• Muscle weakness (myasthenia)
• Impaired coordination
• Vivid or abnormal dreams
• Nausea

Serious Side Effects

Contact your healthcare provider or seek emergency medical attention if you experience:

• Complex sleep behaviors — sleep-walking, sleep-driving, making phone calls, preparing/eating food, engaging in sexual activity while not fully awake with no memory of these events (FDA boxed warning)
• Severe allergic reaction (anaphylaxis) — hives, difficulty breathing, swelling of face/throat
• Severe drowsiness or respiratory depression — especially when combined with opioids or other CNS depressants
• Severe headache with chest pain (possible angioedema)
• Mental health changes — agitation, aggression, hallucinations, depression, suicidal ideation
• Paradoxical reactions — increased insomnia, agitation, or anxiety

Drug Interactions

Major Interactions (Avoid or Use Extreme Caution)

• Opioids (including oxycodone, hydrocodone, fentanyl, morphine) — concurrent use can cause profound sedation, respiratory depression, coma, and death; the FDA requires a boxed warning for this combination
• Other CNS depressants (benzodiazepines, barbiturates, alcohol, antihistamines) — additive sedation and respiratory depression
• Strong CYP3A4 inhibitors (itraconazole, ketoconazole, clarithromycin, ritonavir, nefazodone) — can dramatically increase zolpidem levels

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St. John's Wort) — may decrease zolpidem effectiveness
• CYP1A2 inhibitors (fluvoxamine, ciprofloxacin) — may increase zolpidem levels
• Other sedating medications — additive CNS depression

Dependence and Withdrawal

Zolpidem carries a risk of psychological and physical dependence, even at recommended doses for a few weeks. Withdrawal symptoms may include rebound insomnia, anxiety, tremors, and rarely seizures. Tapering is recommended for patients who have used zolpidem for an extended period.

Precautions & Warnings

• Pregnancy: Zolpidem is FDA Pregnancy Category C. Use during pregnancy only if benefits outweigh risks.
• Breastfeeding: Zolpidem is excreted in breast milk. Use is generally not recommended due to potential sedation in infants.
• Elderly patients: Increased sensitivity; start at lower doses. Higher risk of falls, fractures, and cognitive impairment.
• Liver disease: Zolpidem is extensively metabolized by the liver. Patients with hepatic impairment require dose reduction.
• Respiratory conditions: Use caution in patients with respiratory disease, sleep apnea, or COPD — can suppress respiratory drive.
• History of substance use disorder: Increased risk of misuse and dependence. Use with caution and close monitoring.
• Depression: Zolpidem may worsen depression and increase suicidal ideation.
• Driving and machinery: Do not drive or operate heavy machinery the morning after taking zolpidem. The FDA recommends at least 7-8 hours of sleep after taking zolpidem.
• Alcohol: Do not consume alcohol while taking zolpidem. Combined use can cause profound sedation and respiratory depression.

When to Contact a Clinician

Reach out to your healthcare provider if you experience any of the following:

• Symptoms are not improving or are worsening after starting the medication
• You notice new or unexpected side effects
• You feel you need to take more medication to achieve the same effect (tolerance)
• You are experiencing next-day drowsiness that affects your daily activities
• You are experiencing depression, anxiety, or thoughts of self-harm
• You are having complex sleep behaviors (sleep-walking, sleep-driving)
• You are pregnant or planning to become pregnant
• You have questions about how long you should take this medication
• You want to stop the medication — consult your provider for guidance

Seek emergency care immediately if you experience severe allergic reaction, difficulty breathing, severe drowsiness, or if someone has taken too much zolpidem.